Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Blau Farmaceutica S.A.

Home Clinical Trial Sponsors and OrganizationsBlau Farmaceutica S.A.

Blau Farmaceutica S.A.

Miraflores 222 Norte P28, Santiago, Chile

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

6

4 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

4

66.7%

Phase 3

2

33.3%

Trial Status Distribution

Not yet recruiting

4

66.7%

Recruiting

2

33.3%

Clinical Trials

Trials sponsored by this organization (6)

Study in healthy volunteers to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as a single intravenous injection as well as safety, tolerability and the effects on certain blood values.

Aug 202664 participants

Study in healthy male participants to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as multiple intravenous injections as well as safety, tolerability and the effects on certain blood values.

Aug 2026124 participants

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration

Not yet recruiting

Jun 202368 participants

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration

Not yet recruiting

Jun 202368 participants

Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy

Not yet recruiting

May 202360 participants

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Not yet recruiting

May 2023320 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials6
Approvals
News

Back to Organizations